| Name | 3-amino-4-phenoxy-5-sulfamoylbenzoic acid |
|---|---|
| Synonyms |
Bumetanide Impurity B/ Bumetanide Related Compound A (Desbutyl Bumetanide)
3-amino-5-(aminosulphonyl)-4-phenoxybenzoic acid BuMetanide related coMpound A (Desbutyl) Bumetanide Impurity B Bumetanide Related Compound A Bumetanide Related Compound A, Bumetanide impurity B 3-sulphamoyl-4-phenoxy-5-amino-benzoic acid Bumetanide Impurity 2 (Bumetanide Impurity B) 3-amino-4-phenoxy-5-sulfamylbenzoic acid 3-amino-5-(aminosulphonyl)-4-phenoxybenzoic acid 28-3 Bumetanide Impurity B (Bumetanide Related Compound A) 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid EINECS 248-971-1 Bumetanide Related Compound A Bumetanil impurity B 3-amino-4-phenoxy-5-sulphamyl-benzoic acid 3-Amino-4-phenoxy-5-sulfamoylbenzoic acid (Bumetanide Impurity) Bumetanide Impurity B Desbutyl Bumetanide 3-Amino-4-phenoxy-5-sulfamoylbenzoi Bumetanide impurity B Bumetanide related compound A (Desbutyl Bumetanide) 3-amino-4-phenoxy-5-sulfamoyl-benzoic acid BUTMETANIDERELATEDA Desbutylbumetanide Benzoic acid,3-amino-5-(aMinosulfonyl)-4-phenoxy Bumetanide impurity BQ: What is Bumetanide impurity B Q: What is the CAS Number of Bumetanide impurity B Q: What is the storage condition of Bumetanide impurity B Q: What e the applications of Bumetanide impurity B |
| Density | 1.512g/cm3 |
|---|---|
| Boiling Point | 555.3ºC at 760mmHg |
| Molecular Formula | C13H12N2O5S |
| Molecular Weight | 308.31000 |
| Flash Point | 289.6ºC |
| Exact Mass | 308.04700 |
| PSA | 141.09000 |
| LogP | 3.76900 |
| Vapour Pressure | 3.65E-13mmHg at 25°C |
| Index of Refraction | 1.663 |
| RIDADR | NONH for all modes of transport |
|---|---|
| HS Code | 2935009090 |
|
~75%
28328-54-3 |
| Literature: AUSPEX PHARMACEUTICALS, INC. Patent: US2008/262086 A1, 2008 ; Location in patent: Page/Page column 28 ; |
|
~%
28328-54-3 |
| Literature: Lovens Kemiske Fabrik Produktionsaktieselskab Patent: US3971819 A1, 1976 ; |
|
~%
28328-54-3 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
28328-54-3 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
| Precursor 4 | |
|---|---|
| DownStream 6 | |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |